Pfizer Collaborates With Stakeholders To Raise Awareness About Counterfeit Medicine Dangers


In a bid to enhance public understanding of the risks associated with counterfeit medicine and pharmaceutical products, Pfizer is actively seeking collaboration with various stakeholders. Olayinka Subair, the Country Manager/Cluster Lead for West Africa at Pfizer, has emphasized the significance of collective efforts within the industry to shed light on the perils of counterfeit drugs.

Subair’s call for collaboration came during a visit from Professor Cyril Usifoh, the President of the Pharmaceutical Society of Nigeria, who paid a courtesy visit to the Pfizer Nigeria office. Subair underscored the persistent nature of the counterfeit medicine threat and Pfizer’s endeavor to form partnerships with stakeholders to educate consumers about these deceptive medications.

He stressed the importance of patients having the knowledge necessary to safeguard their well-being from the dangers posed by counterfeiters.

Counterfeit medicines often lack crucial ingredients and proper dosages or may even contain harmful substances. This results in patients who unknowingly consume counterfeit drugs, including those meant to treat life-threatening conditions like cancer and heart disease, losing out on the intended therapeutic effects.

To address the peril that counterfeit medicines pose to patients’ health, Pfizer is actively collaborating with industry stakeholders. The company aims to ensure that patients are equipped with the information needed to steer clear of counterfeit drugs.

Pfizer’s efforts to raise awareness about the growing problem of counterfeit medicines involve seeking collaboration with government agencies, pharmaceutical organizations, medical professionals, pharmacists, and industry partners.

The collective goal is to halt the distribution of counterfeit medicines before they reach patients, furnish consumers with the requisite information to make informed choices, and offer support to healthcare providers within communities.

Professor Cyril Usifoh responded by affirming the Pharmaceutical Society of Nigeria’s commitment to upholding high professional ethics and discipline among its members. He pledged full support to collaborate with Pfizer on this initiative.

He highlighted the Society’s intention to amplify efforts by engaging stakeholders and driving a successful campaign aimed at raising awareness about counterfeit medicines. Professor Usifoh expressed enthusiasm about the potential impact of this joint endeavor.

Reactions from citizens show the level of exposure the populace now have about world events. Grace, an entrepreneur said: “it is rather interesting that Pfizer, one of the chief culprits in the COVID-19 scam/vaccine mandate is suddenly concerned about people’s health.

“Now the same organisation that championed the production of a vaccine that has cause a lot of damage all around the world, and there has not been any form of apology tendered, nor compensation paid for the action, is suddenly particular about patient awareness of fake drugs. I do hope they will be sincere with us by using their own vaccine as the perfect example.”

No contrary opinion from anyone else, all those Ireport247 talked with, responded in like manner as madam Grace.












Share post:




More like this


The Federal Competition and Consumer Protection Commission (FCCPC) has...


The newly appointed Police Public Relations Officer (PPRO) for...

UEFA Champions League: Mbappe Stars As PSG Beat 10-man Barcelona

Luis Enrique returned to Barcelona to knock his former...

Tennis: Nadal Makes Triumphant Return At Barcelona Open

Rafael Nadal enjoyed a winning start at the Barcelona...